home / stock / erfsf / erfsf quote
Last: | $60.23 |
---|---|
Change Percent: | -6.02% |
Open: | $62.71 |
Close: | $60.23 |
High: | $62.71 |
Low: | $58.518 |
Volume: | 1,312 |
Last Trade Date Time: | 05/02/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$60.23 | $62.71 | $60.23 | $62.71 | $58.518 | 1,312 | 05-02-2024 |
$59.15 | $62.85 | $59.15 | $62.85 | $59.15 | 5,514 | 05-01-2024 |
$62.794 | $62.99 | $62.794 | $62.99 | $60 | 1,241 | 04-30-2024 |
$61.788 | $61 | $61.788 | $64.494 | $60.5 | 1,783 | 04-29-2024 |
$60 | $62.45 | $60 | $62.45 | $60 | 1,288 | 04-26-2024 |
$60.01 | $61 | $60.01 | $63.416 | $60.01 | 1,148 | 04-25-2024 |
$61.05 | $64.104 | $61.05 | $64.104 | $60.32 | 10,989 | 04-24-2024 |
$65 | $67.228 | $65 | $68.45 | $63.48 | 4,037 | 04-23-2024 |
$62.5 | $62.29 | $62.5 | $64.7 | $61.82 | 3,131 | 04-22-2024 |
$64.75 | $65.05 | $64.75 | $65.85 | $63.29 | 622 | 04-19-2024 |
$63.035 | $64.622 | $63.035 | $64.622 | $61.25 | 2,307 | 04-17-2024 |
$61.92 | $62.9 | $61.92 | $63.45 | $61.92 | 16,888 | 04-16-2024 |
$62.34 | $64.92 | $62.34 | $67.06 | $62.34 | 1,039 | 04-15-2024 |
$63.434 | $63.67 | $63.434 | $63.67 | $63.434 | 127 | 04-12-2024 |
$64.376 | $65.03 | $64.376 | $65.07 | $64.37 | 269 | 04-11-2024 |
$64.97 | $67.26 | $64.97 | $67.26 | $63.911 | 824 | 04-10-2024 |
$65.246 | $64.63 | $65.246 | $66.162 | $64.63 | 1,617 | 04-09-2024 |
$63.01 | $66.026 | $63.01 | $66.306 | $63.01 | 395 | 04-08-2024 |
$63.594 | $63.01 | $63.594 | $66 | $63.01 | 8,853 | 04-05-2024 |
$66.65 | $65.25 | $66.65 | $66.95 | $65.25 | 201 | 04-04-2024 |
News, Short Squeeze, Breakout and More Instantly...
Eurofins Scientific S.E. Company Name:
ERFSF Stock Symbol:
OTCMKTS Market:
Eurofins Scientific S.E. (ERFSF) is expected to report for Q4 2023 Biodesix Inc. (BDSX) is expected to report $-0.1 for Q4 2023 Tapinator Inc (TAPM) is expected to report for quarter end 2023-12-31 Rapid Micro Biosystems Inc. (RPID) is expected to report $-0.31 for Q4 2023 Galapag...
Eurofins Discovery , an industry-leading provider of products and services for drug discovery research, today announced the launch of DiscoveryAI SAFIRE ( S uite of A DMET Predictions F or I n Silico R efinement and E valuation) . SAFIRE i...
Eurofins MET Labs , part of the global Eurofins (Paris:ERF) network of companies, and a leader in product safety approvals and regulatory certification, is proud to announce the completion of a half-million-dollar expansion of its 10-meter Electromagnetic Compatibility (EMC) Chamber at their Sa...